Valuation: Cuorips Inc.

Market Cap 5.37TCr 34Cr 30Cr 28Cr 25Cr 48Cr 3.19TCr 49Cr 335.24Cr 133.68Cr 1.7TCr 127.36Cr 124.63Cr P/E 2025
-103x
P/E 2026 -56.3x
Enterprise Value 4.98TCr 31Cr 28Cr 26Cr 24Cr 44Cr 2.96TCr 46Cr 310.91Cr 123.98Cr 1.58TCr 118.12Cr 115.58Cr EV / Sales 2025
356x
EV / Sales 2026 255x
Free-Float
77.06%
Yield 2025 *
-
Yield 2026 -
1 day-7.63%
1 week-17.69%
Current month-14.31%
1 month-8.05%
3 months+22.35%
6 months-8.75%
Current year+0.33%
1 week 5,910
Extreme 5910
7,100
1 month 5,910
Extreme 5910
7,490
Current year 3,610
Extreme 3610
12,400
1 year 3,610
Extreme 3610
12,400
3 years 1,549
Extreme 1549
12,400
5 years 1,287
Extreme 1287
12,400
10 years 1,287
Extreme 1287
12,400
Manager TitleAgeSince
Chief Executive Officer 67 01/06/2020
Chief Administrative Officer 45 01/06/2024
Chief Tech/Sci/R&D Officer 71 01/08/2021
Director TitleAgeSince
Director/Board Member 67 01/08/2020
Director/Board Member 71 01/08/2021
Director/Board Member 45 01/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
18/02/25 Others

Chief Technology Officer

24,000 0.2989%
Change 5-day change 1-year change 3-year change Capi.($)
-7.63%-17.69%-10.10%+278.12% 37Cr
-0.24%-3.81%+45.46%+129.10% 1,21600Cr
+1.11%+0.76%+47.23%+81.47% 66TCr
+0.75%-1.54%+32.56%+105.64% 51TCr
-0.36%-3.25%+47.17%+64.58% 38TCr
-0.16%-1.85%+71.08%+40.65% 36TCr
-0.78%-0.52%+30.57%+57.98% 31TCr
-0.80%-0.21%+8.54%+35.56% 29TCr
+0.26%-0.95%+46.27%+69.19% 25TCr
+0.27%-1.48%+36.26%+107.23% 21TCr
Average -0.83%-0.55%+35.50%+96.95% 41.88TCr
Weighted average by Cap. -0.01%+0.03%+42.44%+88.76%

Financials

2025 2026
Net sales 18Cr 11.05L 10L 9L 8L 15.58L 10Cr 16.07L 1.09Cr 43.54L 5.54Cr 41.48L 40.59L 21Cr 13.39L 12.01L 10.97L 10.02L 18.87L 13Cr 19.47L 1.32Cr 52.75L 6.72Cr 50.25L 49.18L
Net income -64Cr -40.67L -36.48L -33.34L -30.43L -57.34L -38Cr -59.14L -4.02Cr -1.6Cr -20Cr -1.53Cr -1.49Cr -102.2Cr -64.54L -57.89L -52.91L -48.29L -90.99L -61Cr -93.86L -6.38Cr -2.54Cr -32Cr -2.42Cr -2.37Cr
Net Debt -479.3Cr -3.03Cr -2.71Cr -2.48Cr -2.26Cr -4.27Cr -284.54Cr -4.4Cr -30Cr -12Cr -151.83Cr -11Cr -11Cr -389.9Cr -2.46Cr -2.21Cr -2.02Cr -1.84Cr -3.47Cr -231.47Cr -3.58Cr -24Cr -9.7Cr -123.51Cr -9.24Cr -9.04Cr
Projected Income Statement - Annual - Cuorips Inc.
Logo Cuorips Inc.
Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The Company provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The Company operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.
Employees
51
Date Price Change Volume
06/26/06 JP¥6,050.00 -7.63% 2,29,400
05/26/05 JP¥6,550.00 -3.82% 1,32,400
04/26/04 JP¥6,810.00 -2.58% 1,87,100
02/26/02 JP¥6,990.00 -0.99% 1,25,400
30/26/30 JP¥7,060.00 -3.95% 2,23,700

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Cuorips Inc.
  1. Stock Market
  2. Stocks
  3. 4894 Stock